Ajanta Pharma Q2 Results: Net profit rises 49% to ₹388 crore, revenue up 33%

At the operating level, the company reported EBITDA of ₹547.6 crore for the quarter. Its EBITDA margin expanded to 30.5% from 24.2% in the corresponding period last year.

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.cnbctv18.com)